|
|
Volumn 333, Issue 6049, 2011, Pages 1569-1571
|
|
Pushing the envelope in neuroblastoma therapy
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACTIVIN RECEPTOR LIKE KINASE 1;
CD135 ANTIGEN;
EFLORNITHINE;
NIFURTIMOX;
SORAFENIB;
ANTINEOPLASTIC AGENT;
ALGORITHM;
CANCER;
CHILD HEALTH;
DISEASE TREATMENT;
DRUG;
DRUG DEVELOPMENT;
GENETIC VARIATION;
HEALTH RISK;
MEDICINE;
NERVOUS SYSTEM DISORDER;
RESEARCH AND DEVELOPMENT;
SURVIVAL;
TUMOR;
AFRICAN TRYPANOSOMIASIS;
APOPTOSIS;
BONE MARROW TRANSPLANTATION;
CANCER CELL;
CANCER SURVIVAL;
CHAGAS DISEASE;
DNA SEQUENCE;
GENE EXPRESSION;
GENE MUTATION;
GENETIC ASSOCIATION;
GENETIC VARIABILITY;
HUMAN;
LEUKEMIA;
NEUROBLASTOMA;
NONHUMAN;
PRIORITY JOURNAL;
PROGNOSIS;
PROTEIN TARGETING;
SHORT SURVEY;
TREATMENT RESPONSE;
TUMOR GENE;
ALGORITHM;
ANIMAL;
CHILD;
CLINICAL TRIAL (TOPIC);
DISEASE MODEL;
GENE EXPRESSION PROFILING;
GENETICS;
MOLECULARLY TARGETED THERAPY;
MOUSE;
NOTE;
PERSONALIZED MEDICINE;
PRESCHOOL CHILD;
ALGORITHMS;
ANIMALS;
ANTINEOPLASTIC AGENTS;
CHILD;
CHILD, PRESCHOOL;
CLINICAL TRIALS AS TOPIC;
DISEASE MODELS, ANIMAL;
GENE EXPRESSION PROFILING;
HUMANS;
INDIVIDUALIZED MEDICINE;
MICE;
MOLECULAR TARGETED THERAPY;
NEUROBLASTOMA;
|
|
EID: 80052925900
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.333.6049.1569 Document Type: Short Survey |
|
Times cited : (6)
|
|
References (0)
|
